Slide 1. Slide 2. Slide 3. Objectives. Reminders and Alerts. Decision Support for Quality Improvement. Unit 6.3: Alerts and Clinical Reminders

Similar documents
A Case Study on Visual Analytics for Optimizing Drug Duplicate Alerts in a Medication Clinical Decision Support System

Creating an alert for GSK vaccines in e-mds EHR

Applying the Goldilocks Principle to Clinical Decision Support. Carla J Maslakowski M.S, M.Ed, RPh

Lessons Learned from Meaningful Use Implementation. Cynthia L. Bero, MPH Partners HealthCare May 19, 2011

A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems.

CMS-3311-P 100 TABLE 6: MEANINGFUL USES OBJECTIVES AND MEASURES FOR 2015 THROUGH 2017

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2015 Tipsheet

Are We Making Smart Pumps Smarter?

Creating a reminder for GSK vaccines in Allscripts Professional EHR

PDMP Tools to Identify Red Flag Situations

Complacency. Some people have their head in the sand and ignore what is happening around them, what s changed, what NEW hazards are there

Meaningful Use Simple Guide

Objectives. Key Elements. ICAHN Targeted Focus Area: Drug Information and Drug Standardization and Distribution 3/24/2014

Costs and Limitations

PCC EHR Meaningful Use Measures. Maria Horn July 18, :15 pm. Including CQM Reports

Emergency Medicine. Brett W. Taylor, MD, FRCP, MHI. Health Informatics. CAEP June 2011

The MetroHealth System. Creating the HIT Organizational Culture at MetroHealth. Creating the HIT Organizational Culture

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group

Avoiding harm in primary care

Session Objectives 11/27/2013

Michael Draheim CIO, Metro South Health Adjunct Professor, UQ Business School. Going Digital Using data to support care

A Case Study on Visual Analytics for Optimizing Drug Duplicate Alerts in a Medication Clinical Decision Support System

QUALITY IMPROVEMENT TOOLS

Final Meaningful Use Objectives for 2017

Final Meaningful Use Objectives for 2017

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education

Nodule Detection process: 1. Click on the patient study to be loaded 2. Click the drop down arrow next to the analysis button and select LNA

Medicare Physician Fee Schedule Final Rule for CY 2018 Appropriate Use Criteria for Advanced Diagnostic Imaging Services Summary

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

Patient Action Sets. Allscripts Touchworks ABOUT THIS GUIDE INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION

Registry Processor Reports

Patient Lists. Allscripts Professional ABOUT THIS GUIDE INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION

Final Meaningful Use Objectives for Program Year 2018

Introducing ValueOptions Clinical Care Alerts

The Human as Hero and Hazard. Human Factors

Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy. Date Prescription will Start Denying at the

Final Meaningful Use Objectives for 2016

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

BLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA

The impact of health information exchange

Patient Lists. Epic ABOUT THIS GUIDE INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION. Please see accompanying full Prescribing Information

Continuous Quality Improvement: Learning from Events

ProScript User Guide. Pharmacy Access Medicines Manager

Analysis of overridden alerts in a drug drug interaction detection system

MU - Selection & Configuration of Measures

EHR Usability Test Report of OneTouch EMR

Bridges to Excellence Asthma Care Recognition Program Guide for Patients 5 years of age and older

POPULATION TRACKER MIDS USER GUIDE

An Oncology Digital Companion for Patient-Reported Outcomes with Electronic Health Record Integration. Dr Zachary Tan

Cancer Decision Support Tool (CDS) - FAQ's

Early Identification of Triggers in Childhood Trauma. Cheri Meadowlark, BCPC Board Certified PTSD Clinician

Complex just became comfortable.

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS

Electronic Support for Public Health Vaccine Adverse Event Reporting System (ESP:VAERS)

Team-Based Decision Support in Diabetes Outcomes and Costs

EVALUATION OF RESEARCH PROPOSAL PhD

Reach Out to Patients for Better Disease Management

The Alabama Regional Extension Center

C. Difficile Testing Protocol

MODULE 6 WORK CULTURE AND LEADERSHIP ETHICS

See Important Reminder at the end of this policy for important regulatory and legal information.

Patient List Inquiries

GLOOKO DREAMED FOR ANDROID USER GUIDE

Effective Strategies to Help Customers Use Their EHR to Improve Quality of Care

Opioid epidemic and PEHP

Global Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

EHR Usability Test Report of Greenway SuccessEHS

This document outlines the clinical risks assessed as AFAP within INRstar.

Rising Threats in the Nation s Drug Epidemic

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Clinical Quality Measure (CQM) Reporting In PCC EHR. Tim Proctor Users Conference 2017

HCV Testing Challenges & Systems-based Solutions

Meaningful Use Overview

GLOOKO FOR ios MIDS USER GUIDE

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Design Issues for Electronics Health Records Using Cloud Computing Technologies

All personnel carrying out any of the functions referred to in Article 23 of Directive 2010/63/EU.

10.2 Summary of the Votes and Considerations for Policy

Overview of the Tobacco Treatment (TOB) Core Measure Set

ABSTRACT. prospective evaluation of CDS implementations rarely occurs, and misuse or flaws in system design are

RIGOR AND REPRODUCIBILITY IN RESEARCH GUIDANCE FOR REVIEWERS

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

EHR Developer Code of Conduct Frequently Asked Questions

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits

Tobacco screening and follow-up if positive for tobacco use

Welcome back to our program!

:Connected care. Norfolk and Suffolk NHS Foundation Trust

Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida

Chapter Goal. Learning Objectives 9/12/2012. Chapter 13. Clinical Decision Making

Meaningful Use Stage 2: ONC Request for Comments. Ivy Baer, Jennifer Faerberg

Understand Medication and Prescriptions

concentrate intravenous solution and other strong potassium solutions

Identifying Hypertension and Diabetes by Mastering IT

Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC

Sleep Apnea Therapy Software Clinician Manual

Drug interaction alerts in software what do general practitioners and pharmacists want?

Optimizing Drug-Dose Checking to Minimize Alert Fatigue

Enhancing Regulators Confidence in your Quality Risk Management Work Products

AETC PRACTICE TRANSFORMATION BASELINE ORGANIZATIONAL ASSESSMENT

Transcription:

Slide 1 Decision Support for Quality Improvement Unit 6.3: Alerts and Clinical Reminders 1 Slide 2 Objectives Analyze the benefits and shortfalls of alerts and clinical reminders 2 Slide 3 Reminders and Alerts the burden of reminders and alerts must not be too high or alert fatigue may cause clinicians to override both important and unimportant alerts, in a manner that compromises the desired safety effect of integrating decision support into CPOE. 3

Slide 4 Alerts and Reminders Nuisance Alert provides little perceived benefit to the prescriber at the time of the alert Alert Fatigue arise when clinicians, either consciously or unconsciously, begin to systematically bypass CDS alerts without regard to their importance, enabling the possibility that a clinically important alert is missed 4 Slide 5 Responses to Clinical Reminders Compliance Reliance Tendency to perform an action when a warning system instructs the user to do so Tendency to refrain from performing an action when the warning system does not indicate that it is necessary 5 Slide 6 Responses to Clinical Reminders Spillover Reactance Clinician performs an action even when not prompted by the reminder system Clinician refrains from performing an action due to a perceived threat to professional autonomy 6

Slide 7 Four Types of Alerts/Reminders Drug Alerts Lab Test Alerts Practice Reminders Administrative Reminders 7 Slide 8 Basic Drug Alerts Drug allergy warnings Drug-drug interactions Duplicate medication or therapeutic duplication alert Basic medication order guidance 8 Slide 9 Advanced Drug Alerts Drug-Lab alerts Drug-Condition interactions Drug-Disease Contraindication alerts Drug-condition alerts aimed at appropriate prescribing 9

Slide 10 Advanced Drug Alerts Drug-age alerts Drug-formulary alerts Dosing guidelines Complex prescribing alerts 10 Slide 11 Evidence to Support Drug Alerts Systematic review examined 20 studies that evaluated the impact of efficacy of computerized drug alerts and prompts 23 of 27 alert types identified demonstrated benefit Improving prescribing behavior Reducing error rates Greatest potential for affecting prescribing Drug-drug interaction alerts Drug-disease contraindication alerts Dosing guidelines based on age 11 Slide 12 Improving Adoption of Drug Alerts Shah and colleagues studied way to improve clinician acceptance of drug alerts in ambulatory care settings Designed a selective set of drug alerts for the ambulatory care setting using a criticality leveling system Minimized workflow disruptions by designating only critical to high-severity alerts to be interruptive to clinician workflow Alert levels: 1: clinician could not proceed with the prescription without eliminating the contraindication; 2: clinicians could proceed if provided an over-ride reason 3: alert displayed at top of screen in red; did not hinder workflow 12

Slide 13 Basic Laboratory Alerts Drug-laboratory alerts Duplicate laboratory testing alert Basic laboratory test order guidance Public health situational awareness 13 Slide 14 Evidence to Support Lab Alerts Research examined the impact of a clinical decision support system that generated reminders of previous lab test results Found that the proportion of unnecessarily repeated tests dropped significantly Features of the Alert Alert was automatically prompted and was part of the clinician workflow User could not deactivate the alert output Most recent laboratory result for viral serology test an its date was automatically retrieved from the patient s EHR Alert was displayed at the time and location of decision making (before the user ordered an unnecessarily repeated test 14 Slide 15 Practice Reminders Guiding Provides recommended treatment Critiquing Monitoring Checks prescriptions against clinical practice guidelines Helps provider follow the patient 15

Slide 16 Practice Reminders Challenges Incorrect Guidelines Too generic guideline Patient data inconsistency Inappropriate action Potential Risk 16 Slide 17 Administrative Reminders Medical Coding Quality Improvement Guides prescribers to document to support appropriate medical coding Guides the collection of QI indicator data 17 Slide 18 Success Factors: Alerts Specificity Alert clinically important for the patient Sensitivity Alert generated in all dangerous cases 18

Slide 19 Success Factors: Alerts Information Content Clear, concise, unambiguous Justification noted Further information accessible Alternative actions presented 19 Slide 20 Success Factors: Alerts Workflow Directed to right person at right time Specialty-specific; Knowledge-specific Avoid repetition Safe, efficient handling High threshold Reasons for non-compliance Promotes action Speed; Screen design; minimize work 20 Slide 21 Summary Alerts and reminders have the potential to improve patient safety Types of alerts and reminders include: drug and lab test alerts, practice reminders, and administrative reminders Nuisance alerts provide little perceived benefit to the prescriber at the time of the alert, causing clinician frustration and alert fatigue Successful alerts are specific, sensitive, clear and concise. Successful alerts support clinical workflow and allow for safe, efficient responses. 21